Citation Impact
Citing Papers
Risk Factors for Venous Thromboembolism
2003 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Dextran 70 in prophylaxis of thromboembolic disease after surgery: a clinically oriented randomized double-blind trial.
1975
Prophylaxis of postoperative leg vine thrombosis by low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial.
1975
Parenteral Anticoagulants
2008
Parenteral Anticoagulants
2012 Standout
Binding of heparin on the surface of cultured human endothelial cells
1978
Immobilization of the direct thrombin inhibitor‐bivalirudin on 316L stainless steel via polydopamine and the resulting effects on hemocompatibility in vitro
2012
Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial
2002 Standout
Subcutaneous Heparin Versus Low-Molecular-Weight Heparin as Thromboprophylaxis in Patients Undergoing Colorectal Surgery
2001
The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg
1988
Sustained Bacteremia in 26 Patients with a Permanent Endocardial Pacemaker: Assessment of Wire Removal
1993
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Prevention of Venous Thromboembolism in General Surgical Patients
1988
Antithrombotic Therapy for VTE Disease
2016 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
The Efficacy of Pneumatic Compression Stockings in the Prevention of Pulmonary Embolism After Cardiac Surgery
1996
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
1988
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Hemodynamic Deterioration Following Radiofrequency Ablation of the Atrioventricular Conduction System
1997
Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces
2004 StandoutNobel
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Systematic autoregulation counteracts the carotid baroreflex
1991 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery
2004
Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for reduced thrombogenicity
1993
Heparin and Low-Molecular-Weight Heparin
2004
Xanthine oxidoreductase is central to the evolution and function of the innate immune system
2003 StandoutNobel
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
How were new medicines discovered?
2011 Standout
Intravenous heparin dosing
1993
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
PaO2 during anaesthesia and years of smoking predict late postoperative hypoxaemia and complications after upper abdominal surgery in patients without preoperative cardiopulmonary dysfunction
2000
Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy
1996
Prevention of Venous Thromboembolism
2008 Standout
Blood compatibility of photografted hydrogel coatings
2010 StandoutNobel
Disseminated Intravascular Coagulation
1999 Standout
Heparin
1991
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
Prevention of Venous Thromboembolism
1998
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
2003
A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection
1977 Standout
Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery
2000
Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites
1997 StandoutScience
Maturation of the hemostatic system during childhood
1992 Standout
Infection Control in Intravenous Therapy
1973 Standout
Heparin-Associated Thrombocytopenia: A Comparison of Three Heparin Preparations
1980
Prognosis of Patients with Complete Heart Block or Arrhythmic Syncope
1976
Prevention of Venous Thromboembolism
1981
Prevention of Venous Thromboembolism
1992
Kinetics of intravenously administered heparin in normal humans
1982
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Factor V Leiden (G1691A) and Prothrombin Gene G20210A Mutations as Potential Risk Factors for Venous Thromboembolism after Total Hip or Total Knee Replacement Surgery
2002 StandoutNobel
SUBCUTANEOUS HEPARIN
1974
Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.
1990
Low molecular weight heparin
1992
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
NONTHROMBOGENIC ARTERIAL CATHETERS
1970
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Heparin surface film formation through adsorption of colloidal particles studied by ellipsometry and scanning electron microscopy
1982
Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis
1986
Prevention of venous thromboembolism after general surgery
1987
Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization.
1984
Improved survival rates in dogs after extracorporeal circulation by improved control of heparin levels
1974
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Low-Molecular-Weight Heparins
1997 Standout
Disseminated intravascular coagulation due to malignancy.
1990
Fibrin Sleeve Formation on Indwelling Subclavian Central Venous Catheters
1971
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Electrochemical Glucose Sensors and Their Applications in Diabetes Management
2008 Standout
Calf Compression for Prevention of Thromboembolism Following Hip Surgery
1983
RATES OF VENOUS THROMBOSIS AFTER GENERAL SURGERY: COMBINED RESULTS OF RANDOMISED CLINICAL TRIALS
1986
Prevention of Venous Thromboembolism
1995
Quantitative discrimination of hepatic reticuloendothelial clearance and phagocytic killing
1994
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Heparin kinetics in venous thrombosis and pulmonary embolism.
1976
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
2010 StandoutNobel
Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis
2005 Standout
Low molecular weight heparin
1992
Reduction of Mortality in General Medical In-patients by Low-Dose Heparin Prophylaxis
1982
Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy
2003
Heparin Pharmacokinetics: Increased Requirements in Pulmonary Embolism
1978
Works of H. Lagergren being referenced
Effect of low-dose heparin on the phagocytic and catabolic function in the reticulo-endothelial system in man during surgery.
1976
The Elimination from Plasma of Intravenous Heparin An Experimental Study on Dogs and Humans
1963
Platelet and plasma coagulation compatibility of heparinized and sulphated surfaces
1979
Auger electron spectroscopy studies of glutardialdehyde-stabilized heparin Hexadecylamine hydrochloride films
1979
Preparation and evaluation of “nonthrombogenic” surfaces
1968
EFFECT OF LOW-DOSE HEPARIN ON INCIDENCE OF POSTOPERATIVE PULMONARY EMBOLISM DETECTED BY PHOTOSCANNING
1974
Survey of pacemaker treatment in Denmark, Finland, Norway and Sweden, in 1969.
1972
TRANSVENOUS ELECTRODES IN LONG‐TERM STIMULATION WITH CARDIAC PACING
1969
Ten‐year Follow‐up on 1,000 Patients with Transvenous Electrodes
1984
Influence of thrombin-induced disseminated intravascular coagulation on res functions in rabbits
1976
Animal Experiments with Biogalvanic and Biofuel Cells
1976
Phagocytic and catabolic function of the reticuloendothelial system in dogs subjected to defibrinogenation
1976
The Stability of Glutardialdehyde-Stabilized 35-Heparinized Surfaces in Contact with Blood
1977
305 cases of permanent intravenous pacemaker treatment for Adams-Stokes syndrome.
1966
A new method for preparing nonthrombogenic plastic surfaces
1967
Deleterious Effects of Cardiac Pacing in a Patient with Mitral Insufficiency
1977
Prevention of Platelet Adhesion and Aggregation by a Glutardialdehyde-Stabilized Heparin Surface
1977
EFFECT OF LOW-DOSE HEPARIN PROPHYLAXIS ON ARTERIAL OXYGEN TENSION AFTER HIGH LAPAROTOMY
1976
Effect of Changes in Ventricular Rate on Cardiac Output and Central Pressures at Rest and During Exercise in Patients with Artificial Pacemakers
1967